The evidence is solid but not definitive, as the conclusions rely on the absence of changes in spatial breadth and would benefit from clearer statistical justification and a more cautious ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of its Biologics License Application (BLA) for imsidolimab ...

A multivariate analysis of electroencephalography activity reveals super-additive enhancements to the neural encoding of audiovisual stimuli, providing new insights into how the brain integrates ...

Explore how India can transform grassroots robotics talent into a robust economy, leveraging education, innovation, and local ...

IntroductionIn December 2025, Zscaler ThreatLabz discovered a campaign linked to APT37 (also known as ScarCruft, Ruby Sleet, and Velvet Chollima), which is a DPRK-backed threat group. In this campaign ...

By Pooja Toshniwal Paharia Preclinical studies increasingly place circular RNAs at the intersection of thermogenic programming and organelle stress control, raising the possibility that these stable ...

US FDA accepts Vanda Pharmaceuticals’ BLA for imsidolimab to treat Generalized Pustular Psoriasis: Washington Friday, February 27, 2026, 17:00 Hrs [IST] Vanda Pharmaceuticals In ...

Researchers shamelessly copy viral strategies to get mRNA medicines into cells in one piece (Illustration courtesy of Joe Luciani ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

Michael Saylor reveals Solana as the deployment platform for programmable digital credit, backed by Strategy's STRF framework.

Gothenburg, February 27, 2026 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next-generation cancer treatments based on its proprietary iTANK platform, tod ...